Comparison of prognostic scores and surgical approaches to treat spinal metastatic tumors: A review of 57 cases
© Yilmazlar et al; licensee BioMed Central Ltd. 2008
Received: 21 January 2008
Accepted: 28 August 2008
Published: 28 August 2008
Surgical treatment of metastatic spinal cord compression with or without neural deficit is controversial. Karnofsky and Tokuhashi scores have been proposed for prognosis of spinal metastasis. Here, we conducted a retrospective analysis of Karnofsky and modified Tokuhashi scores in 57 consecutive patients undergoing surgery for secondary spinal metastases to evaluate the value of these scores in aiding decision making for surgery. Comparison of preoperative Karnofsky and modified Tokuhashi scores with the type of the surgical approach for each patient revealed that both scores not only reliably estimate life expectancy, but also objectively improved surgical decisions. When the general status of the patient is poor (i.e., Karnofsky score less than 40% or modified Tokuhashi score of 5 or greater), palliative treatments and radiotherapy, rather than surgery, should be considered.
Karnofsky and Tokuhashi scores are generally used to evaluate the life expectancy and prognosis of patients with secondary spinal metastases prior to spinal surgery for metastatic malignancy [1, 3]. Spinal metastasis is associated with pain and neurological deficits, which greatly impair quality of life. For this reason, treatment of the disease is essential. Spinal metastases can extend into the epidural or intradural/intramedullary space to cause a mass effect, while vertebral metastasis can grow into the adjacent epidural space to cause pathologic fractures. Patients can suffer from severe pain even if the neural structures are not affected. Surgery, radiotherapy, or vertebroplasty, as single procedures or combined, are effective in preventing neurological deficits, stabilizing the spine, or achieving a cure . Boland et al. reported that early intensive therapy can prevent spine compression and improve the quality of life of the patients .
Surgical approaches are generally planned according to the side of the metastasis . If the anterior or middle column is affected, then an anterolateral approach would be preferred. If the posterior column is affected, then posterior approach would be chosen . Combined anterior and posterior approaches would be selected if the metastasis has encircled the spinal cord. However, the side of the pathology is not the only factor affecting the surgical strategy. The type of primary pathology, the extension of the metastasis, and the general and neurologic status of the patient should also be taken into account. Therefore, standard simplified scoring systems are needed to aid decisions relating to the surgical approach and the type of the surgery. Proper selected scoring systems may predict life expectancy for spinal metastases after operation. The aim of this study compare preoperative Karnofsky and modified Tokuhashi scores with the type of the surgical approach in 57 patients with spinal metastases treated surgically and to evaluate the value of these scores in aiding decision making for surgery.
Materials and methods
This study was conducted on 57 consecutive patients who underwent surgery for treatment of spinal metastasis at Uludag University, School of Medicine, Department of Neurosurgery from 1995 to 2005. The surgical approach to tumor resection and spinal reconstruction was determined dependent on the segments of spine involved with tumor (cervical, thoracic, lumbar, sacral), location of the tumor within the spine segment (anterior, posterior, right, left, or circumferential to neural elements).
The study population had a mean age of 48.9 ± 16.3 years and consisted of 36 males (63.1%) and 21 females (36.9%). Preoperative assessments included a medical history, a history of primary tumors, and spinal magnetic resonance imaging. All symptoms, physical findings, and neurological findings were also recorded. Following surgery, neurological assessments were performed and complications were noted. Patient survival, radiologic recurrence, and final physical and neurological states were also assessed.
Karnofsky performance status scale
Normal, no complaints, no evidence of disease
Able to carry on normal activity, minor signs and symptoms
Normal activities with effort, some signs or symptoms
Care for self, unable to carry on normal activity or do active work
Requires occasional assistance, cares for most needs
Requires considerable assistance and frequent care
Disabled, requires special care and assistance
Severely disabled, hospitalized, death not imminent
Very sick, hospitalized, active supportive care needed
Moribund, fatal processes are progressing rapidly
Modified Tokuhashi scoring system for preoperative assessment of metastatic spine tumor prognosis.
General health condition
good = 0, bad = 1
Extra-spinal bone metastasis
no = 0 , yes = 1
Other vertebral metastasis
no = 0, yes = 1
Other visceral organ metastasis
no = 0, yes = 1
Primary site of the cancer
limited = 0, diffuse = 1
normal = 0, paresis = 1, plegia = 2
All data are expressed as mean ± standard deviation. Statistical analyses were performed using pairwise comparison of means, correlation, Pearson's test, and Fisher's exact test. A probability value less than 0.05 was considered significant.
The type of primary cancer varied among patients, with 24 (42%) having lung cancer, 8 (14%) multiple myeloma, 6 (10.5%) gastrointestinal system cancer, 4 (7.0%) non Hodgkin lymphoma, 2 (3.5%) Hodgkin lymphoma, 2 (3.5%) breast cancer, 2 (3.5%) thyroid cancer, 1 (1.8%) renal cell cancer, 1 (1.8%) testicular cancer, 1 (1.8%) ovarian cancer, 1 (1.8%) bladder cancer, and 1 (1.8%) laryngeal cancer. The primary site of cancer could not be found in four patients. In 32 (56.2%) patients, spinal metastasis was the presenting symptom, and pain was the major symptom in all of the patients. Fifty-four (94.8%) patients had neurological deficits. The metastasis was located in the cervical region in 4 (7%) patients, the thoracic region in 28 (49.2%) patients, and the lumbar region in 16 (28%) patients. Six (10.5%) patients had metastasis in the thoracolumbar junction, and 2 (3.5%) had metastasis in the servicothoracal junction. One patient (1.8%) had intramedullar metastasis.
The mean preoperative Karnofsky index was 74.2 ± 17.8 (range, 40 – 100). Thirty-two (56.1%) patients were assigned a Karnofsky index of over 80 (low risk), 22 (38.6%) patients had a Karnofsky index of 50–70 (moderate risk), and 3 (5.3%) patients had an index under 40 (low risk). The mean modified Tokuhashi score was 2.14 ± 1.19 (range, 1 – 5). The modified Tokuhashi index was 0–1 (low risk) in 25 patients (43.8%), 2–4 (moderate risk) in 31 (54.4%) patients, and 5 (high risk) in 1 (1.8%) patient. Karnofsky versus modified Tokuhashi indices were correlated in the low risk (R = 0.91), moderate risk (R = 0.99), and high risk (R = 1.00) subgroups.
Comparison of surgical approaches and mean survival time among Karnofsky's groups.
Mean survival (months)
28.2 ± 16.3§
19.6 ± 12.1* §
4.7 ± 3.6*
Comparison surgical approaches and mean survival time among modified Tokuhashi's groups.
Modified Tokuhashi score
Mean survival (months)
21.4 ± 10.7* §
11.4 ± 10.2* §
The mean follow up was 11.2 ± 10.4 months (range, 1 – 48 months). The mean survival time was 15.5 ± 11.5 months (range, 1 – 48 months). 6 patients (10.5%) develop local tumor recurrens at the previous level of decompression. Among the patients with a Kornofsky score over 80, the mean survival time was 28.2 ± 16.3 months. This value decreased to 19.6 ± 12.1 months in patients with a Karnofsky score of 50–70 and 4.7 ± 3.6 months in patients with a Karnofsky score under 40. Among the patients with a modified Tokuhashi score 0–1, the survival time was 21.4 ± 10.7 months. Among those with a score of 2–4, the survival time was 11.4 ± 10.2 months. The patient with a modified Tokuhashi score of 5 survived for one month. Statistical results were summarized in the tables 3 and 4.
Karnofsky and Tokuhashi scoring systems are currently used to determine the prognosis of the patients with metastatic spinal tumors before and after surgery [9, 10]. The prognosis of spinal tumors is related to many factors such as the general condition of the patient, their ability to carry on normal activity and care for them self, and the degree of their disability. Other important factors include the presence of extraspinal bone or other organ metastasis, the histological type of the primary tumor, the limited or diffuse nature of the primary tumor, and paralysis. These prognostic factors must be taken into account for objective determination of treatment modality. This is especially true in cases of radical surgery, where the operability of the patient should be thoroughly assessed using classification systems. Therefore, in cancer patients appropriate clinical and radiological scoring methods should be chosen with determination without any delay.
Here, anterolateral and combined approaches were performed in 33.3% of patients (19/57)with Karnofsky scores of 80–100 and in 26.3% of patients (15/57) with modified Tokuhashi scores of 0–1. Posterior approach was performed in 22.8% of patients (13/57) with Karnofsky scores 80–100 and in 17.5% of patients (10/57) with modified Tokuhashi scores of 0–1. In these patients, posterior spinal cord compressions were the main component of the tumor and spinal stabilization did not required. On the other hand, posterior approaches were performed in 33.3% of patients with a Karnofsky score of 50–70 and in 43.8% of patients with modified Tokuhashi score of 2–4. Sundaresan et al stated that effective surgical treatment of neoplastic compression requires anteroposterior resection in most patients with good score to achieve the goal of total tumor resection . Zarzycki D et al., also suggested that effective surgical treatment of neoplastic compression in most patients needs anteroposterior resection using instrumentation to achieve total tumor resection . Thus, combined and anterolateral approaches are applied to the patients with good scores. In patients with good scores and limited lesions, as in these cases, surgery can be performed. Nevertheless, surgical modalities even in patients without any neurological deficits are still controversial, and deciding on a treatment remains difficult. According to Taneichi et al., surgery should be performed if lesions affect 50–60% of the vertebral body, since these lesions increase the risk of vertebral body collapse . Additionally, lesions affecting the posterior cortex of the vertebra body and extending to the spinal cord without causing any neurological deficits carry potential risks for neurological deficits. Therefore, these lesions should be operated on even if the spinal column is stable.
For the patients without organ metastasis, the Karnofsky index may be more suitable than the Tokuhashi index for determination of treatment. However, the use of both scoring systems is most appropriate when determining treatment for spinal metastasis, especially when considering surgery. Both scoring systems separately have incapacity for determination of the clinical status of the patients. The Karnofsky scoring system is widely used for prognosis of central nervous system tumors. High Karnofsky scores are generally associated with long survival times. According to North et al., life expectancy and extended survival are highest for patients with limited pathology in one spinal segment and Karnofsky scores over 70% . In accord with this report, we found that patients with Karnofsky scores of 80–100 and modified Tokuhashi scores less than 2 had the highest survival times. When deciding upon surgery, the Karnofsky score should be taken into consideration if the modified Tokuhashi score is less than 2. If the general condition is not good (Karnofsky < 40%, modified Tokuhashi > 5), then palliative treatment modalities should be considered. Tokuhashi scoring systems was suggested in estimation of early death, which can be used to predict of life expectancy for selecting surgical procedure of spinal metastases after operation [2, 3, 15] Radiotherapy, alone, can be used to treat patients who are not in a good general condition, which can be used to avoid major operation and are suffering pain [16, 17]. Alternatively, it can be used in cases where surgery would not be effective for technical reasons . Radiotherapy has been shown to be effective after surgery and can reduce pain, even if the tumor has not been totally removed [16, 18].
Tumor recurrence after the surgery is one of the biggest problems associated with spinal metastasis. Nazarian et al. reported that, following surgery for spinal metastasis, recurrence was present at the same spinal level (local recurrence) in 11% of patients and at other spinal levels in 16.5% of patients . In another study, local recurrence was observed in 8.4% of patients . In our study, local recurrens rate was 10.5%. Palliative radiotherapy and supportive care should be considered for treatment of local recurrences without neurological deficits.
In patients suffering from spinal metastasis with or without neurological deficits, surgery leads to functional recovery in low and moderate risk patients but cannot increase survival in high-risk patients. Patients in good general condition survive the longest and are good candidates for surgery, taking the vertical or horizontal extension of the tumor into consideration. The goal of the surgery should be to delay or eliminate local recurrence to prevent neurological deficits. Proper use of both modified Tokuhashi and Karnofsky scores to select surgery for patients based on life expectancy can objectively improve surgical decisions in cancer patients with spinal metastases. In future practices, comparison the results of patients with and without surgery having similar scores and comparison the predicted life expectancy and survival time may improve our treatment efforts.
- Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S: Scoring system for the preoperative evaluation of metastatic spine tumour prognosis. Spine. 1990, 15: 1110-13. 10.1097/00007632-199011010-00005.View ArticlePubMedGoogle Scholar
- Ulmar B, Naumann U, Catalkaya S, Muche R, Cakir B, Schmidt R, Reichel H, Huch K: Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol. 2007, 14 (2): 998-1004. 10.1245/s10434-006-9000-5. Epub 2006 Nov 3View ArticlePubMedGoogle Scholar
- Ulmar B, Richter M, Cakir B, Muche R, Puhl W, Huch K: The Tokuhashi score: significant predictive value for the life expectancy of patients with breast cancer with spinal metastases. Spine. 2005, 30 (19): 2222-6. 10.1097/01.brs.0000181055.10977.5b.View ArticlePubMedGoogle Scholar
- Cotten A, Dewatre F, Cortet B, Assaker R, Leblond D, Duquesnoy B, Chastanet P, Clarisse J: Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methylmethacrylate at clinical follow-up. Radiology. 1996, 200: 525-30.View ArticlePubMedGoogle Scholar
- Boland PJ, Lane JM, Sundaresan N: Metastatic disease of the spine. Clin Orthop. 1982, 169: 95-102.PubMedGoogle Scholar
- Onimus M, Papin P, Gangloff S, Laurain JM: Résultats du traitement chirurgical des métastases vertébrales dorsales et lombaires. Rachis. 1995, 7: 275-82.Google Scholar
- Bridwell KH, Jenny AB, Saul T, Rich KM, Grubb RL: Posterior spinal instrumentation with posterolateral decompression and debulking for metastatic thoracic and lumbar spine disease. Limitations of the technique. Spine. 1988, 13: 1383-94. 10.1097/00007632-198812000-00010.View ArticlePubMedGoogle Scholar
- Karnofsky DA: Clinical evaluation of anticancer drugs: cancer chemotherapy. Gann Monogr. 1967, 2: 223-31.Google Scholar
- Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine. 2005, 1;30 (19): 2186-91. 10.1097/01.brs.0000180401.06919.a5.View ArticleGoogle Scholar
- Enkaoua EA, Doursounian L, Chatellier G, Mabesoone F, Aimard T, Saillant G: Vertebral metastases: a critical appreciation of the preoperative prognostic Tokuhashi score in a series of 71 cases. Spine. 1997, 1;22 (19): 2293-8. 10.1097/00007632-199710010-00020.View ArticleGoogle Scholar
- Sundaresan N, Sachdev VP, Holland JF, Moore F, Sung M, Paciucci PA, Wu LT, Kelligher K, Hough L: Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol. 1995, 13 (9): 2330-5.PubMedGoogle Scholar
- Zarzycki D, Tesiorowski M, Jasiewicz B, Lipik E, Kacki W: Indications and range of surgery in the treatment of spine metastatic tumours. Ortop Traumatol Rehabil. 2003, 5 (2): 172-9.PubMedGoogle Scholar
- Taneichi H, Kaneda K, Takeda N, Abumi K, Satoh S: Risk factors and probability of vertebral body collapse in metastases of thoracic and lumbar spine. Spine. 1997, 22: 239-45. 10.1097/00007632-199702010-00002.View ArticlePubMedGoogle Scholar
- North RB, LaRocca VR, Schwartz J, North CA, Zahurak M, Davis RF, McAfee PC: Surgical management of spinal metastases: analysis of prognostic factors during a 10-year experience. J Neurosurg Spine. 2005, 2: 564-73.View ArticlePubMedGoogle Scholar
- Zou XN, Grejs A, Li HS, Høy K, Hansen ES, Bünger C: Estimation of life expectancy for selecting surgical procedure and predicting prognosis of extradural spinal metastases Ai Zheng. Ai Zheng. 2006, 25 (11): 1406-10. (Abstract)PubMedGoogle Scholar
- Hoskin PJ: Radiotherapy in the management of bone pain. Clin Orthop. 1995, 312: 105-19.PubMedGoogle Scholar
- Schocker JD, Brady LW: Radiation therapy for bone metastasis. Clin Orthop. 1982, 169: 38-43.PubMedGoogle Scholar
- Agarawal JP, Swangsilpa T, Linden van der Y, Rades D, Jeremic B, Hoskin PJ: The role of external beam radiotherapy in the management of bone metastases. Clin Oncol (R Coll Radiol). 2006, 18: 747-60.View ArticleGoogle Scholar
- Chataigner H, Onimus M: Surgery in spinal metastasis without spinal cord compression: indications and strategy related to the risk of recurrence. Eur Spine J. 2000, 9: 523-7. 10.1007/s005860000163.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.